Fluxome
INVESTOR RELATIONS
ProductsCompany
NewsInvestor Relations
BackgroundContact


SEVENTURE PARTNERS

Being one of the leading venture capital firms in Europe, Seventure Partners manages €500m and have been investing since 1997 in innovative businesses with high growth potential within Information & Communication Technologies and in Life Sciences.

The Life Sciences team invests all over Europe. Its 4 preferred sectors are Biotech & Pharmaceuticals, Medtech, Industrial Biotech & Cleantech, and Lifestyle Healthcare & nutrition.

A typical investment ranges from €500k to €10 m per round; up to €20 m per company, from early to later stage.

Seventure is a subsidiary of Natixis Private Equity, the asset management company of Natixis, with over €4.2 bn in private equity investments.

More information may be retrieved by visiting the Seventure Partners web page at www.seventure.fr

Seventure Partners